28 42

Cited 0 times in

Productivity Loss of Rheumatoid Arthritis Patients according to the Their Stages of the Disease Activity Score

DC Field Value Language
dc.contributor.authorBae, SC-
dc.contributor.authorCha, JH-
dc.contributor.authorChoe, JY-
dc.contributor.authorChoi, SJ-
dc.contributor.authorCho, SK-
dc.contributor.authorChung, WT-
dc.contributor.authorJoung, CI-
dc.contributor.authorJung, YO-
dc.contributor.authorKang, YM-
dc.contributor.authorKim, DW-
dc.contributor.authorKim, J-
dc.contributor.authorKim, YJ-
dc.contributor.authorLee, CK-
dc.contributor.authorLee, HS-
dc.contributor.authorLee, J-
dc.contributor.authorLee, SH-
dc.contributor.authorLee, SH-
dc.contributor.authorLee, SS-
dc.contributor.authorLee, YA-
dc.contributor.authorNah, SS-
dc.contributor.authorShim, SC-
dc.contributor.authorSong, GG-
dc.contributor.authorSuh, CH-
dc.contributor.authorWon, S-
dc.contributor.authorYoo, WH-
dc.contributor.authorYoon, BY-
dc.date.accessioned2020-01-13T05:03:47Z-
dc.date.available2020-01-13T05:03:47Z-
dc.date.issued2018-
dc.identifier.issn2093940X-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/18003-
dc.description.abstractOBJECTIVE: Productivity loss was compared by 3-stage of disease activity and associations between higher disease activity and high productivity loss were identified.
METHODS: Data were extracted from Rheumatoid Arthritis (RA) Patient-reported Outcomes Research, which enrolled 2,000 RA patients (>20-year) on disease-modifying-antirheumatic-drugs (DMARDs) (≥6-month) from December 2012 to June 2013. This included 1,457 RA patients with the disease activity score (DAS-28-ESR) in their medical charts. Productivity loss in time and indirect cost was estimated using The World Health Organization Health and Work Performance Questionnaire (HPQ). Baseline characteristics and productivity loss outcomes were compared according to DAS-28-ESR groups.
RESULTS: 84.4% were females, 54.2% had low DAS-28-ESR (5.1). Patients with moderate to high DAS-28-ESR had higher lost productivity time (LPT) and monthly costs of LPT than those with low DAS-28-ESR (time in hours: 110.0±58.4 vs. 132.4±57.2 vs. 71.5±52.0, p<0.0001: monthly costs of LPT in 1,000 Korean won: 1,097±607 vs. 1,302±554 vs. 741±531, p<0.0001). Multiple regression analyses revealed significant associations with high LPT in high (adjusted odds ratio [OR]=3.87, 95% confidence interval [CI]: 2.18∼6.87) and moderate DAS-28-ESR (adjusted OR=1.88, 95% CI: 1.41∼2.52) compared to low DAS-28-ESR. In addition, positive associations with high monthly costs of LPT were observed in high (adjusted OR=3.45, 95% CI: 1.98∼5.99) and moderate DAS-28-ESR (adjusted OR=1.93, 95% CI: 1.43∼2.54) compared to low DAS-28-ESR.
CONCLUSION: Timely therapeutic strategies should be taken into consideration given that the RA patients with moderate to high DAS-28-ESR showed strong associations with high productivity loss for effective management of RA.
-
dc.language.isoen-
dc.titleProductivity Loss of Rheumatoid Arthritis Patients according to the Their Stages of the Disease Activity Score-
dc.typeArticle-
dc.subject.keywordRheumatoid arthritis-
dc.subject.keywordProductivity loss-
dc.subject.keywordDisease activity score-
dc.subject.keywordPatient reported outcome measures-
dc.contributor.affiliatedAuthor서, 창희-
dc.type.localJournal Papers-
dc.identifier.doi10.4078/jrd.2018.25.2.122-
dc.citation.titleJournal of rheumatic diseases-
dc.citation.title대한류마티스학회지-
dc.citation.volume25-
dc.citation.number2-
dc.citation.date2018-
dc.citation.startPage122-
dc.citation.endPage130-
dc.identifier.bibliographicCitationJournal of rheumatic diseases, 25(2):122-130, 2018-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn22334718-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Rheumatology
Files in This Item:
Productivity Loss of Rheumatoid Arthritis Patients according to the Their Stages of the Disease Activity Score.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse